CD177 and autoimmune disease: Similarly, the anti‐CD177 monoclonal antibody Hu‐AMLX7909 has been explored for its ability to selectively deplete proinflammatory low‐density granulocytes (LDGs) in autoimmune disorders like ANCA‐associated vasculitis.438